menu
    • menu

    Company profile for Pinteon Therapeutics

    NEW Drugs in Dev: 1
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    SERVICES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We aim to protect and preserve brain function in patients suffering from tauopathies. Millions of people around the world are living with diseases such as traumatic brain injury (TBI), chronic traumatic encephalopathy (CTE), Alzheimer’s disease (AD) and progressive supranuclear palsy (PSP). We are inspired by the perseverance of patients and caregivers navigating the uncertainty of these devastating neurodegenerative disea...
    We aim to protect and preserve brain function in patients suffering from tauopathies. Millions of people around the world are living with diseases such as traumatic brain injury (TBI), chronic traumatic encephalopathy (CTE), Alzheimer’s disease (AD) and progressive supranuclear palsy (PSP). We are inspired by the perseverance of patients and caregivers navigating the uncertainty of these devastating neurodegenerative diseases. Their determination to fight for a better future motivates us to aggressively pursue and target toxic tau. We are moving with focus, urgency and commitment to bring our novel therapy to these patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Pinteon TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1188 Centre Street Newton Center, Massachusetts, 02459
    Telephone
    Telephone
    917-607-0015
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.pinteon.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/pinteon-therapeutics/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pinteon Extends Collaboration with Lonza for Manufacturing PNT001, a Novel Tau Antibody Targeting Alzheimer's Disease and Traumatic Brain Injury
    Pinteon Extends Collaboration with Lonza for Manufacturing PNT001, a Novel Tau Antibody Targeting Alzheimer's Disease and Traumatic Brain Injury

    24 Jun 2021

    // PRESS RELEASE

    https://www.lonza.com/news/2021-06-24-09-00

    PRESS RELEASE
    24 Jun 2021
    Share Share
    Pinteon Therapeutics Announces $3 Million Award
    Pinteon Therapeutics Announces $3 Million Award

    17 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210617005096/en

    BUSINESSWIRE
    17 Jun 2021
    Share Share
    Pinteon Announces $3 Million Award to Support Phase 1 Study of PNT001
    Pinteon Announces $3 Million Award to Support Phase 1 Study of PNT001

    16 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210617005096/en

    BUSINESSWIRE
    16 Jun 2021
    Share Share
    Pinteon Announces First Patient Dosed in Phase 1 Study of PNT001
    Pinteon Announces First Patient Dosed in Phase 1 Study of PNT001

    06 Apr 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210406005121/en

    BUSINESSWIRE
    06 Apr 2021
    Share Share
    Pinteon Therapeutics Announces First Patient Dosed in Phase 1 Study of PNT001
    Pinteon Therapeutics Announces First Patient Dosed in Phase 1 Study of PNT001

    06 Apr 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210406005121/en/Pinteon-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1-Study-of-PNT001-in-Patients-with-Acute-Traumatic-Brain-Injury

    BUSINESSWIRE
    06 Apr 2021
    Share Share

    Services

    Upload your portfolio for free, ask us

    Drug Product Manufacturing

    Click here to discover the service providers for Drug Product Manufacturing

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search